Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2Phase 1 2Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Genitourinary 5Thoracic 4CNS 4Gynecologic 3Gastrointestinal 3Plasma cell 2Head & Neck 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 2

Interventions

Cyclophosphamide 10fludarabine 8Dexamethasone 8Lenalidomide 6Bortezomib 5Granulocyte Colony-Stimulating Factor 468Ga-pentixafor 4Melphalan 3Filgrastim 3Positron Emission Tomography Computed Tomography 2Fluorodeoxyglucose F18 2Blood Specimen Collection 2tocilizumab 1selinexor 1ruxolitinib 1pomalidomide 1pembrolizumab 1methyl prednisolonate 1ixazomib 1ioversol 1inebilizumab 1iberdomide 1fludarabine phosphate 1eltrombopag 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1blinatumomab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Fluorodeoxyglucose F18 × Plasma cell × Clear all
NCT06385652 2026-04-16

PET Imaging Study of 68Ga-NB381 in Multiple Myeloma

Peking University First Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Plasma cell

Multiple Myeloma

NCT06717113 2025-06-06

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Peking University First Hospital

Phase EARLY_PHASE1 Recruiting
50 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡